| Pharmaceutical benefits for which a dangerous drug fee applies |
| Column 1
Listed drug | Column 2
Form |
| Alprazolam | Tablet 250 micrograms |
| Alprazolam | Tablet 500 micrograms |
| Alprazolam | Tablet 1 mg |
| Buprenorphine | Injection (modified release) 8 mg in 0.16 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 16 mg in 0.32 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 24 mg in 0.48 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 32 mg in 0.64 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 64 mg in 0.18 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 96 mg in 0.27 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 100 mg in 0.5 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 128 mg in 0.36 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 160 mg in 0.45 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 300 mg in 1.5 mL pre‑filled syringe |
| Buprenorphine | Tablet (sublingual) 400 micrograms (as hydrochloride) |
| Buprenorphine | Tablet (sublingual) 2 mg (as hydrochloride) |
| Buprenorphine | Tablet (sublingual) 8 mg (as hydrochloride) |
| Buprenorphine | Transdermal patch 5 mg |
| Buprenorphine | Transdermal patch 10 mg |
| Buprenorphine | Transdermal patch 15 mg |
| Buprenorphine | Transdermal patch 20 mg |
| Buprenorphine | Transdermal patch 25 mg |
| Buprenorphine | Transdermal patch 30 mg |
| Buprenorphine | Transdermal patch 40 mg |
| Buprenorphine with naloxone | Film (soluble) 2 mg (as hydrochloride)‑0.5 mg (as hydrochloride) |
| Buprenorphine with naloxone | Film (soluble) 8 mg (as hydrochloride)‑2 mg (as hydrochloride) |
| Codeine | Tablet containing codeine phosphate hemihydrate 30 mg |
| Dexamfetamine | Tablet containing dexamfetamine sulfate 5 mg |
| Fentanyl | Lozenge 200 micrograms (as citrate) |
| Fentanyl | Lozenge 400 micrograms (as citrate) |
| Fentanyl | Lozenge 600 micrograms (as citrate) |
| Fentanyl | Lozenge 800 micrograms (as citrate) |
| Fentanyl | Lozenge 1200 micrograms (as citrate) |
| Fentanyl | Lozenge 1600 micrograms (as citrate) |
| Fentanyl | Tablet (orally disintegrating) 100 micrograms (as citrate) |
| Fentanyl | Tablet (orally disintegrating) 200 micrograms (as citrate) |
| Fentanyl | Tablet (orally disintegrating) 400 micrograms (as citrate) |
| Fentanyl | Tablet (orally disintegrating) 600 micrograms (as citrate) |
| Fentanyl | Tablet (orally disintegrating) 800 micrograms (as citrate) |
| Fentanyl | Tablet (sublingual) 100 micrograms (as citrate) |
| Fentanyl | Tablet (sublingual) 200 micrograms (as citrate) |
| Fentanyl | Tablet (sublingual) 300 micrograms (as citrate) |
| Fentanyl | Tablet (sublingual) 400 micrograms (as citrate) |
| Fentanyl | Tablet (sublingual) 600 micrograms (as citrate) |
| Fentanyl | Tablet (sublingual) 800 micrograms (as citrate) |
| Fentanyl | Transdermal patch 1.28 mg |
| Fentanyl | Transdermal patch 2.063 mg |
| Fentanyl | Transdermal patch 2.1 mg |
| Fentanyl | Transdermal patch 2.55 mg |
| Fentanyl | Transdermal patch 4.125 mg |
| Fentanyl | Transdermal patch 4.2 mg |
| Fentanyl | Transdermal patch 5.10 mg |
| Fentanyl | Transdermal patch 7.65 mg |
| Fentanyl | Transdermal patch 8.25 mg |
| Fentanyl | Transdermal patch 8.4 mg |
| Fentanyl | Transdermal patch 10.20 mg |
| Fentanyl | Transdermal patch 12.375 mg |
| Fentanyl | Transdermal patch 12.6 mg |
| Fentanyl | Transdermal patch 16.5 mg |
| Fentanyl | Transdermal patch 16.8 mg |
| Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL |
| Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL |
| Hydromorphone | Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL |
| Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg |
| Hydromorphone | Tablet containing hydromorphone hydrochloride 4 mg |
| Hydromorphone | Tablet containing hydromorphone hydrochloride 8 mg |
| Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 20 mg |
| Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 30 mg |
| Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 40 mg |
| Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 50 mg |
| Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 60 mg |
| Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 70 mg |
| Methadone | Injection containing methadone hydrochloride 10 mg in 1 mL |
| Methadone | Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 1 L bottle, 1 mL |
| Methadone | Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL |
| Methadone | Tablet containing methadone hydrochloride 10 mg |
| Methylphenidate | Capsule containing methylphenidate hydrochloride 10 mg (modified release) |
| Methylphenidate | Capsule containing methylphenidate hydrochloride 20 mg (modified release) |
| Methylphenidate | Capsule containing methylphenidate hydrochloride 30 mg (modified release) |
| Methylphenidate | Capsule containing methylphenidate hydrochloride 40 mg (modified release) |
| Methylphenidate | Capsule containing methylphenidate hydrochloride 60 mg (modified release) |
| Methylphenidate | Tablet containing methylphenidate hydrochloride 10 mg |
| Methylphenidate | Tablet containing methylphenidate hydrochloride 18 mg (extended release) |
| Methylphenidate | Tablet containing methylphenidate hydrochloride 27 mg (extended release) |
| Methylphenidate | Tablet containing methylphenidate hydrochloride 36 mg (extended release) |
| Methylphenidate | Tablet containing methylphenidate hydrochloride 54 mg (extended release) |
| Morphine | Capsule containing morphine sulfate pentahydrate 10 mg (containing sustained release pellets) |
| Morphine | Capsule containing morphine sulfate pentahydrate 20 mg (containing sustained release pellets) |
| Morphine | Capsule containing morphine sulfate pentahydrate 50 mg (containing sustained release pellets) |
| Morphine | Capsule containing morphine sulfate pentahydrate 100 mg (containing sustained release pellets) |
| Morphine | Capsule containing morphine sulfate pentahydrate 30 mg (controlled release) |
| Morphine | Capsule containing morphine sulfate pentahydrate 60 mg (controlled release) |
| Morphine | Capsule containing morphine sulfate pentahydrate 90 mg (controlled release) |
| Morphine | Capsule containing morphine sulfate pentahydrate 120 mg (controlled release) |
| Morphine | Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL |
| Morphine | Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL |
| Morphine | Injection containing morphine hydrochloride trihydrate 50 mg in 5 mL |
| Morphine | Injection containing morphine hydrochloride trihydrate 100 mg in 5 mL |
| Morphine | Injection containing morphine sulfate pentahydrate 10 mg in 1 mL |
| Morphine | Injection containing morphine sulfate pentahydrate 15 mg in 1 mL |
| Morphine | Injection containing morphine sulfate pentahydrate 30 mg in 1 mL |
| Morphine | Oral solution containing morphine hydrochloride trihydrate 2 mg per mL, 1 mL |
| Morphine | Oral solution containing morphine hydrochloride trihydrate 5 mg per mL, 1 mL |
| Morphine | Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 1 mL |
| Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 20 mg per sachet |
| Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 30 mg per sachet |
| Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 60 mg per sachet |
| Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 100 mg per sachet |
| Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 200 mg per sachet |
| Morphine | Tablet containing morphine sulfate pentahydrate 10 mg |
| Morphine | Tablet containing morphine sulfate pentahydrate 20 mg |
| Morphine | Tablet containing morphine sulfate pentahydrate 5 mg (controlled release) |
| Morphine | Tablet containing morphine sulfate pentahydrate 10 mg (controlled release) |
| Morphine | Tablet containing morphine sulfate pentahydrate 15 mg (controlled release) |
| Morphine | Tablet containing morphine sulfate pentahydrate 30 mg (controlled release) |
| Morphine | Tablet containing morphine sulfate pentahydrate 60 mg (controlled release) |
| Morphine | Tablet containing morphine sulfate pentahydrate 100 mg (controlled release) |
| Morphine | Tablet containing morphine sulfate pentahydrate 200 mg (controlled release) |
| Oxycodone | Capsule containing oxycodone hydrochloride 5 mg |
| Oxycodone | Capsule containing oxycodone hydrochloride 10 mg |
| Oxycodone | Capsule containing oxycodone hydrochloride 20 mg |
| Oxycodone | Oral solution containing oxycodone hydrochloride 1 mg per mL, 1 mL |
| Oxycodone | Suppository 30 mg (as pectinate) |
| Oxycodone | Tablet containing oxycodone hydrochloride 5 mg |
| Oxycodone | Tablet containing oxycodone hydrochloride 10 mg (controlled release) |
| Oxycodone | Tablet containing oxycodone hydrochloride 15 mg (controlled release) |
| Oxycodone | Tablet containing oxycodone hydrochloride 20 mg (controlled release) |
| Oxycodone | Tablet containing oxycodone hydrochloride 30 mg (controlled release) |
| Oxycodone | Tablet containing oxycodone hydrochloride 40 mg (controlled release) |
| Oxycodone | Tablet containing oxycodone hydrochloride 80 mg (controlled release) |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 2.5 mg with naloxone hydrochloride 1.25 mg |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 5 mg with naloxone hydrochloride 2.5 mg |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 10 mg with naloxone hydrochloride 5 mg |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 15 mg with naloxone hydrochloride 7.5 mg |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 20 mg with naloxone hydrochloride 10 mg |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 30 mg with naloxone hydrochloride 15 mg |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 40 mg with naloxone hydrochloride 20 mg |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 60 mg with naloxone hydrochloride 30 mg |
| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 80 mg with naloxone hydrochloride 40 mg |
| Tapentadol | Tablet (modified release) 50 mg (as hydrochloride) |
| Tapentadol | Tablet (modified release) 100 mg (as hydrochloride) |
| Tapentadol | Tablet (modified release) 150 mg (as hydrochloride) |
| Tapentadol | Tablet (modified release) 200 mg (as hydrochloride) |
| Tapentadol | Tablet (modified release) 250 mg (as hydrochloride) |
| Pharmaceutical benefits to be supplied as complete packs only |
| Column 1
Listed drug | Column 2
Form |
| Abiraterone and methylprednisolone | Pack containing 120 tablets abiraterone acetate 125 mg and 60 tablets methylprednisolone 4 mg |
| Aciclovir | Eye ointment 30 mg per g, 4.5 g |
| Aclidinium | Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses |
| Aclidinium with formoterol | Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses |
| Adapalene with benzoyl peroxide | Gel 1 mg‑25 mg per g, 30 g |
| Amoxicillin | Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL |
| Amoxicillin | Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL |
| Amoxicillin | Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL |
| Amoxicillin | Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL (s19A) |
| Amoxicillin | Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL |
| Amoxicillin with clavulanic acid | Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL |
| Amoxicillin with clavulanic acid | Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL |
| Apremilast | Pack containing 4 tablets 10 mg, 4 tablets 20 mg and 19 tablets 30 mg |
| Atenolol | Oral solution 50 mg in 10 mL, 300 mL |
| Atovaquone | Oral suspension 750 mg per 5 mL, 210 mL |
| Atropine | Eye drops containing atropine sulfate monohydrate 10 mg per mL, 15 mL |
| Azithromycin | Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL |
| Beclometasone | Pressurised inhalation containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC‑free formulation) |
| Beclometasone | Pressurised inhalation containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC‑free formulation) |
| Beclometasone | Pressurised inhalation in breath actuated device containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC‑free formulation) |
| Beclometasone | Pressurised inhalation in breath actuated device containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC‑free formulation) |
| Beclometasone with formoterol | Pressurised inhalation containing beclometasone dipropionate 100 micrograms and formoterol fumarate dihydrate 6 micrograms per dose,120 dose |
| Beclometasone with formoterol | Pressurised inhalation containing beclometasone dipropionate 200 micrograms and formoterol fumarate dihydrate 6 micrograms per dose, 120 doses |
| Beclometasone with formoterol and glycopyrronium | Pressurised inhalation containing beclometasone dipropionate 100 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses |
| Beclometasone with formoterol and glycopyrronium | Pressurised inhalation containing beclometasone dipropionate 200 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses |
| Benzydamine | Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL |
| Betaine | Oral powder 180 g |
| Betaxolol | Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL |
| Bimatoprost | Eye drops 300 micrograms per mL, 3 mL |
| Bimatoprost | Eye drops 300 micrograms per mL, single dose units 0.4 mL, 30 |
| Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL |
| Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, single dose units 0.4 mL, 30 |
| Bisacodyl | Enemas 10 mg in 5 mL, 25 |
| Brigatinib | Pack containing 7 tablets 90 mg and 21 tablets 180 mg |
| Brimonidine | Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL |
| Brimonidine | Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL |
| Brimonidine with timolol | Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL |
| Brinzolamide | Eye drops 10 mg per mL, 5 mL |
| Brinzolamide with brimonidine | Eye drops 10 mg brinzolamide with 2 mg brimonidine tartrate per mL, 5 mL |
| Brinzolamide with timolol | Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL |
| Budesonide | Nebuliser suspension 500 micrograms in 2 mL single dose units, 30 |
| Budesonide | Nebuliser suspension 1 mg in 2 mL single dose units, 30 |
| Budesonide | Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses |
| Budesonide | Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses |
| Budesonide | Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses |
| Budesonide with formoterol | Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses |
| Budesonide with formoterol | Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses |
| Budesonide with formoterol | Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses |
| Budesonide with formoterol | Pressurised inhalation containing budesonide 50 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses |
| Budesonide with formoterol | Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses |
| Budesonide with formoterol | Pressurised inhalation containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses |
| Budesonide with glycopyrronium and formoterol | Pressurised inhalation containing budesonide 160 micrograms with glycopyrronium 7.2 micrograms and formoterol fumarate dihydrate 5 micrograms per dose, 120 doses |
| Buprenorphine | Injection (modified release) 100 mg in 0.5 mL pre‑filled syringe |
| Buprenorphine | Injection (modified release) 300 mg in 1.5 mL pre‑filled syringe |
| Calcipotriol with betamethasone | Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g |
| Calcipotriol with betamethasone | Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g |
| Captopril | Oral solution 5 mg per mL, 95 mL |
| Carbamazepine | Oral suspension 100 mg per 5 mL, 300 mL |
| Carbomer | Eye gel 2 mg per g, 10 g |
| Carmellose | Eye drops containing carmellose sodium 5 mg per mL, 10 mL |
| Carmellose | Eye drops containing carmellose sodium 5 mg per mL, 15 mL |
| Carmellose | Eye drops containing carmellose sodium 10 mg per mL, 15 mL |
| Carmellose with glycerin | Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, 15 mL |
| Carmustine | Implants 7.7 mg, 8 |
| Cefaclor | Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL |
| Cefaclor | Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL |
| Cefalexin | Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL |
| Cefalexin | Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL |
| Cefalexin | Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL (s19A) |
| Cefuroxime | Powder for oral suspension 125 mg (as axetil) per 5 mL, 100 mL |
| Chloramphenicol | Eye drops 5 mg per mL, 10 mL |
| Chlorpromazine | Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL |
| Ciclesonide | Pressurised inhalation 80 micrograms per dose, 120 doses (CFC‑free formulation) |
| Ciclesonide | Pressurised inhalation 160 micrograms per dose, 120 doses (CFC‑free formulation) |
| Ciclosporin | Eye drops 1 mg per mL, single dose units 0.3 mL, 30 |
| Ciprofloxacin | Ear drops 3 mg (as hydrochloride) per mL, 5 mL |
| Citrulline | Tablet 1 g, 300 (Citrulline Easy) |
| Clarithromycin | Powder for oral liquid 250 mg per 5 mL, 50 mL |
| Clobetasol | Shampoo containing clobetasol propionate 500 micrograms per mL, 125 mL |
| Clonazepam | Oral liquid 2.5 mg per mL, 10 mL |
| Clozapine | Oral liquid 50 mg per mL, 100 mL |
| Degarelix | Powder for injection 120 mg (as acetate), 2, injection set |
| Desmopressin | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations, 5 mL, USP (Apotex) |
| Desmopressin | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL |
| Dexamethasone | Eye drops 1 mg per mL, 5 mL |
| Dexamethasone with framycetin and gramicidin | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL |
| Diazepam | Oral liquid 10 mg per 10 mL, 100 mL |
| Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL |
| Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL |
| Electrolyte replacement, oral | Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10 |
| Erythromycin | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL |
| Erythromycin | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL |
| Escitalopram | Oral solution 20 mg (as oxalate) per mL, 15 mL |
| Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) |
| Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) |
| Estradiol | Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 |
| Estradiol | Transdermal patches 390 micrograms, 8 |
| Estradiol | Transdermal patches 585 micrograms, 8 |
| Estradiol | Transdermal patches 780 micrograms, 8 |
| Estradiol | Transdermal patches 1.17 mg, 8 |
| Estradiol | Transdermal patches 1.56 mg, 8 |
| Estradiol | Transdermal patches 2 mg, 4 |
| Estradiol | Transdermal patches 3.8 mg, 4 |
| Estradiol | Transdermal patches 5.7 mg, 4 |
| Estradiol | Transdermal patches 7.6 mg, 4 |
| Estradiol | Transdermal patches 750 micrograms (as hemihydrate), 8 |
| Estradiol | Transdermal patches 1.5 mg (as hemihydrate), 8 |
| Estradiol | Transdermal patches 3 mg (as hemihydrate), 8 |
| Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg |
| Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg |
| Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate |
| Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate |
| Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 |
| Estradiol with norethisterone | Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 |
| Estriol | Pessaries 500 micrograms, 15 |
| Estriol | Vaginal cream 1 mg per g, 15 g |
| Ethosuximide | Oral solution 250 mg per 5 mL, 200 mL |
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) |
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) |
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) |
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) |
| Ferrous sulfate | Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL |
| Flucloxacillin | Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL |
| Flucloxacillin | Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL |
| Fluorometholone | Eye drops 1 mg per mL, 5 mL |
| Fluorometholone | Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL |
| Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses |
| Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses |
| Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses |
| Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with umeclidinium
62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses |
| Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses |
| Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses |
| Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses |
| Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses |
| Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses |
| Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC‑free formulation) |
| Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC‑free formulation) |
| Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC‑free formulation) |
| Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses |
| Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses |
| Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses |
| Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses |
| Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses |
| Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses |
| Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) |
| Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) |
| Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) |
| Formoterol | Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses |
| Formoterol | Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses |
| Framycetin | Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL |
| Furosemide | Oral solution 10 mg per mL, 30 mL |
| Gentamicin | Eye drops 3 mg (as sulfate) per mL, 5 mL |
| Glyceryl trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses |
| Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg |
| Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg |
| Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 84 tablets bicalutamide 50 mg |
| Haloperidol | Oral solution 2 mg per mL, 100 mL |
| Hyaluronic acid | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL |
| Hyaluronic acid | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL |
| Hydrocortisone | Cream containing hydrocortisone acetate 10 mg per g, 50 g |
| Hydrocortisone | Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g |
| Hydrocortisone | Ointment containing hydrocortisone acetate 10 mg per g, 50 g |
| Hypromellose | 0.3% w/v eye drops, 10 mL (preservative free) |
| Hypromellose | Eye drops 3 mg per mL, 10 mL |
| Hypromellose | Eye drops 5 mg per mL, 15 mL |
| Hypromellose with carbomer 980 | Ocular lubricating gel 3 mg‑2 mg per g, 10 g |
| Hypromellose with dextran | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL |
| Ketoconazole | Cream 20 mg per g, 30 g |
| Ketoconazole | Shampoo 20 mg per g, 60 mL |
| Lacosamide | Oral solution 10 mg per mL, 200 mL |
| Larotrectinib | Oral solution 20 mg per mL (as sulfate), 50 mL, 2 |
| Latanoprost | Eye drops 50 micrograms per mL, 2.5 mL |
| Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL |
| Leuprorelin and bicalutamide | Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg |
| Leuprorelin and bicalutamide | Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg |
| Leuprorelin and bicalutamide | Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg |
| Levetiracetam | Oral solution 100 mg per mL, 300 mL |
| Lumacaftor with ivacaftor | Sachet containing granules, lumacaftor 100 mg and ivacaftor 125 mg |
| Lumacaftor with ivacaftor | Sachet containing granules, lumacaftor 150 mg and ivacaftor 188 mg |
| Macrogol 3350 | Powder for oral solution 510 g |
| Macrogol 3350 | Sachets containing powder for oral solution 13.125 g with electrolytes, 30 |
| Mercaptopurine | Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL |
| Metronidazole | Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL |
| Metronidazole | Suppositories 500 mg, 10 |
| Miconazole | Cream containing miconazole nitrate 20 mg per g, 30 g |
| Miconazole | Cream containing miconazole nitrate 20 mg per g, 70 g |
| Miconazole | Powder containing miconazole nitrate 20 mg per g, 30 g |
| Miconazole | Tincture 20 mg per mL, 30 mL |
| Mifepristone and misoprostol | Pack containing 1 tablet mifepristone 200 mg and 4 tablets misoprostol 200 micrograms |
| Mupirocin | Nasal ointment 20 mg (as calcium) per g, 3 g |
| Mupirocin | Nasal ointment 20 mg (as calcium) per g, 5 g |
| Mycobacterium bovis (Bacillus Calmette and Guerin (BCG)) Danish 1331 strain | Single dose pack containing powder for irrigation 30 mg, 4 vials |
| Mycophenolic acid | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL |
| Nafarelin | Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses |
| Naloxone | Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 |
| Naloxone | Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 (s19A) |
| Naproxen | Oral suspension 125 mg per 5 mL, 474 mL |
| Netupitant with palonosetron | Capsule containing netupitant 300 mg with palonosetron 500 microgram (as hydrochloride) |
| Nicorandil | Tablets 10 mg, 60 |
| Nicorandil | Tablets 20 mg, 60 |
| Nirmatrelvir and ritonavir | Pack containing 4 tablets nirmatrelvir 150 mg and 2 tablets ritonavir 100 mg, 5 |
| Onasemnogene abeparvovec | Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 8 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 1 vial solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 5.5 mL and 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 2 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 3 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 4 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 5 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 6 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 7 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 8 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Onasemnogene abeparvovec | Pack containing 9 vials solution for I.V. infusion 20 trillion vector genomes per mL, 8.3 mL |
| Ondansetron | Syrup 4 mg (as hydrochloride dihydrate) per 5 mL, 50 mL |
| Oxybutynin | Transdermal patches 36 mg, 8 |
| Ozanimod | Pack containing 4 capsules 230 micrograms and 3 capsules 460 micrograms |
| Paracetamol | Oral liquid 120 mg per 5 mL, 100 mL |
| Paracetamol | Oral liquid 240 mg per 5 mL, 200 mL |
| Paraffin | Eye drops containing liquid paraffin, glycerol, tyloxapol, poloxamer‑188, trometamol hydrochloride, trometamol, cetalkonium chloride, 10 mL (preservative free) |
| Paraffin | Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g |
| Peginterferon beta‑1a | Pack containing single use injection pens containing 63 micrograms in 0.5 mL and 94 micrograms in 0.5 mL |
| Permethrin | Cream 50 mg per g, 30 g |
| Phenytoin | Oral suspension 30 mg per 5 mL, 500 mL |
| Pilocarpine | Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL |
| Pilocarpine | Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL |
| Pilocarpine | Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL |
| Pimecrolimus | Cream 10 mg per g, 15 g |
| Polyethylene glycol 400 with propylene glycol | Eye drops 4 mg‑3 mg per mL, 15 mL |
| Prednisolone | Oral solution 5 mg (as sodium phosphate) per mL, 30 mL |
| Prednisolone with phenylephrine | Eye drops containing prednisolone acetate 10 mg with phenylephrine hydrochloride 1.2 mg per mL, 10 mL |
| Rifampicin | Syrup 100 mg per 5 mL, 60 mL |
| Risdiplam | Powder for oral solution 750 micrograms per mL, 80 mL |
| Risperidone | Oral solution 1 mg per mL, 100 mL |
| Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 |
| Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 |
| Salbutamol | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 |
| Salbutamol | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 |
| Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) |
| Salmeterol | Powder for oral inhalation in breath actuated device 50 micrograms (as xinafoate) per dose, 60 doses |
| Semaglutide | Solution for injection 2 mg in 1.5 mL pre‑filled pen |
| Semaglutide | Solution for injection 4 mg in 3 mL pre‑filled pen |
| Silver sulfadiazine | Cream 10 mg per g, 50 g |
| Sirolimus | Oral solution 1 mg per mL, 60 mL |
| Sterculia with Frangula bark | Granules 620 mg‑80 mg per g, 500 g |
| Tafluprost | Eye drops 15 micrograms per mL, single dose units 0.3 mL, 30 |
| Testosterone | Transdermal cream 50 mg per mL, 50 mL |
| Testosterone | Transdermal gel 50 mg in 5 g sachet, 30 |
| Testosterone | Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 |
| Testosterone | Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses |
| Theophylline | Oral solution 133.3 mg per 25 mL, 500 mL |
| Timolol | Eye drops 5 mg (as maleate) per mL, 5 mL |
| Timolol | Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL |
| Tiotropium | Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations) |
| Tiotropium with olodaterol | Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses |
| Tobramycin | Eye drops 3 mg per mL, 5 mL |
| Tobramycin | Eye ointment 3 mg per g, 3.5 g |
| Tramadol | Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL |
| Travoprost | Eye drops 40 micrograms per mL, 2.5 mL |
| Travoprost with timolol | Eye drops 40 micrograms travoprost with timolol 5 mg (as maleate) per mL, 2.5 mL |
| Triamcinolone with neomycin, gramicidin and nystatin | Ear drops containing triamcinolone acetonide 0.9 mg with neomycin 2.25 mg (as sulfate), gramicidin 225 micrograms and nystatin 90,000 units per mL, 7.5 mL |
| Triamcinolone with neomycin, gramicidin and nystatin | Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g |
| Trimethoprim with sulfamethoxazole | Paediatric oral suspension 40 mg‑200 mg per 5 mL, 100 mL |
| Umeclidinium | Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses |
| Umeclidinium with vilanterol | Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses |
| Varenicline | Box containing 11 tablets 0.5 mg (as tartrate) and 14 tablets 1 mg (as tartrate) in the first pack and 28 tablets 1 mg (as tartrate) in the second pack |
| Venetoclax | Pack containing 14 tablets venetoclax 10 mg and 7 tablets venetoclax 50 mg and 7 tablets venetoclax 100 mg and 14 tablets venetoclax 100 mg |